EdgarLookup

Jefferson Capital, Inc. / DE — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Jefferson Capital, Inc. / DE filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
30.6%
Profit Margin
Net income ÷ revenue
9%
Return on Assets
Net income ÷ assets
3.38x
Debt-to-Equity
Total liabilities ÷ equity
+41.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $613.29M Mar 13, 2026
FY2025 Dec 31, 2024 $433.34M Mar 13, 2026
FY2025 Dec 31, 2023 $323.07M Mar 13, 2026

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $187.97M Mar 13, 2026
FY2025 Dec 31, 2024 $128.89M Mar 13, 2026
FY2025 Dec 31, 2023 $111.52M Mar 13, 2026

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $316.50M Mar 13, 2026
FY2025 Dec 31, 2024 $220.27M Mar 13, 2026
FY2025 Dec 31, 2023 $164.05M Mar 13, 2026

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $268.81M Mar 13, 2026
FY2025 Dec 31, 2024 $168.21M Mar 13, 2026
FY2025 Dec 31, 2023 $120.22M Mar 13, 2026

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.09B Mar 13, 2026
FY2025 Dec 31, 2024 $1.65B Mar 13, 2026

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.61B Mar 13, 2026
FY2025 Dec 31, 2024 $1.27B Mar 13, 2026

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $476.14M Mar 13, 2026
FY2025 Dec 31, 2024 $382.53M Mar 13, 2026
FY2025 Dec 31, 2023 $303.59M Mar 13, 2026

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $58.01M Mar 13, 2026
FY2025 Dec 31, 2024 $57.68M Mar 13, 2026
FY2025 Dec 31, 2023 $57.17M Mar 13, 2026

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $522.63M Mar 13, 2026
FY2025 Dec 31, 2024 $398.12M Mar 13, 2026

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $23.23M Mar 13, 2026
FY2025 Dec 31, 2024 $35.51M Mar 13, 2026
FY2025 Dec 31, 2023 $14.37M Mar 13, 2026

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.75B Mar 13, 2026

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 5 Mar 13, 2026

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 5 Mar 13, 2026

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 58.30M Mar 13, 2026
FY2025 Dec 31, 2024 0 Mar 13, 2026